IV Ensure
Life Sciences
IV Ensure has developed a solution to the 50%+ hospital readmission rates resulting from non-adherence to home infusion treatment plans caused by the shortages of qualified case managers, nurses and funding for home visits.
Why we invested:
-
"We could not be more pleased to have Boyd Street Ventures as an investor. Their management team and Strategic Advisory Board can be a great source of insight, particularly in the areas of strategy and operations, and they are actively engaged in the honing for success."
Jesse McCool Co-Founder & CEO, Wheeler Bio -
"James has been extremely helpful in making important introductions for us. I appreciate the fact that he’s always asking me about our plans to grow even faster, and it seems that every time I talk to him he has another great idea for a potential new customer."
Nathan Den Herder Founder & CEO, Ardley